Pharmaceutical composition for invigorating liver and eliminating lipid as well as preparation method, preparation and application thereof

Abstract

The invention discloses a pharmaceutical composition for invigorating liver and eliminating lipid as well as a preparation method, preparation and application thereof. The pharmaceutical composition for invigorating liver and eliminating lipid comprises the following raw materials in parts by weight: 10-20 parts of radix salviae miltiorrhizae, 3-7 parts of radix notoginseng, 10-20 parts of rhizomazedoariae, 12-30 parts of fructus crataegi, 12-30 parts of radix astragali, 5-15 parts of pericarpium citri reticulatae viride, 10-20 parts of radix paeoniae rubra, 10-20 parts of rhizoma curcumae longae, 10-20 parts of rhizoma alismatis, 10-20 parts of flos chrysanthemi, 10-20 parts of folium nelumbinis and 5-15 parts of radix glycyrrhizae; the preparation obtained by steps of pretreatment, radix notoginseng crushing, volatile oil inclusion, water-soluble extract extraction and mixing can be a soup, a pill, a granule, a tablet, a capsule, a mixture or other clinically appropriate dosage forms prepared by adding pharmaceutically acceptable excipients into the pharmaceutical composition for invigorating liver and eliminating lipid; and the application is application of the pharmaceutical composition for invigorating liver and eliminating lipid to preparation of medicines for preventing / treating non-alcoholic fatty liver. The pharmaceutical composition provided by the invention can significantly reduce deposition of blood lipids in the liver and improve the liver function to prevent and treat non-alcoholic fatty liver.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for invigorating the liver and reducing fat, as well as its preparation method, preparation and application. Background technique [0002] According to its onset characteristics and clinical manifestations, traditional Chinese medicine classifies nonalcoholic fatty liver disease into the categories of hypochondriac pain, fullness, turbid phlegm, and liver addiction. Traditional Chinese medicine believes that the pathogenesis of nonalcoholic fatty liver disease is related to phlegm, dampness, and blood stasis, and turbid phlegm and blood stasis play a key role in the occurrence and development of this disease. Phlegm turbidity and blood stasis can cause phlegm and blood stasis to intertwine or phlegm and blood stasis to intersect, just as it is said in "On the Origin and Symptoms of All Diseases: Phlegm-retention Diseases of the Dynasties"...

AI Technical Summary

Problems solved by technology

NAFLD has become an increasingly important cause of chronic liver disease and seriously endangers public health, but there is still a lack of ideal treatment options

Images